EAU 2014 - Poster: OnabotulinumtoxinA reduces urinary incontinence and improves quality of life in overactive bladder patients regardless of use of clean intermittent catheterisation or the presence of urinary tract infection

STOCKHOLM, SWEDEN (UroToday.com) - Presented by Karel Everaert,¹ Jennifer Gruenenfelder,² Heinrich Schulte-Baukloh,³ Steven Guard,⁴ Yan Zheng,⁵ David Sussman⁶ at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

¹Ghent University Hospital, Gent, Belgium; ²Orange County Urology Associates, Laguna Hills, CA, USA; ³St. Hedwig-Krankenhaus, Berlin, Germany; ⁴Allergan, Ltd., Marlow, UK; ⁵Allergan, Inc., Bridgewater, NJ, USA; ⁶Rowan University School of Osteopathic Medicine, Stratford, NJ, USA